Form 4: Immunovant Chief Medical Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
William L. Macias, Chief Medical Officer of Immunovant, Inc., sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On October 16, 2024, William L. Macias, the Chief Medical Officer of Immunovant, Inc., sold 2,627 shares of common stock at a weighted average price of $28.79.
- These shares were sold to cover tax withholding obligations associated with the vesting of 5,479 restricted stock units (RSUs) granted on April 12, 2023.
- An additional 561 shares were sold on the same day at a weighted average price of $28.79 to cover tax obligations related to the vesting of 1,167 RSUs granted on June 11, 2021.
- The sales were mandated by Immunovant's policy requiring tax obligations to be funded through 'sell to cover' transactions and do not represent discretionary sales by Macias.
- Following these transactions, Macias beneficially owns 365,144 shares of Immunovant common stock.
Sentiment
Score: 6
Explanation: The document reflects a routine transaction (sell to cover taxes) and doesn't indicate any significant positive or negative sentiment regarding the company's prospects.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and employees.
Key Dates
| Date | Description |
|---|---|
| 2021-06-11 | Date of grant of 18,674 restricted stock units (RSUs). |
| 2023-04-12 | Date of grant of 87,664 restricted stock units (RSUs). |
| 2024-10-12 | Vesting date of 5,479 RSUs granted on April 12, 2023. |
| 2024-10-13 | Vesting date of 1,167 RSUs granted on June 11, 2021. |
| 2024-10-16 | Date of share sales to cover tax obligations. |
| 2024-10-18 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.